NES
EW icon

New England Securities’s Edwards Lifesciences EW Stock Holding History

New England Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$125K Buy
5,898
+4,680
+384% +$94K 0.04% 368
2014
Q3 		$21K Buy
1,218
+1,200
+6,667% +$18.9K 0.01% 889
2014
Q2 		$0 Hold
18
– – ﹤0.01% 1763
2014
Q1 		$0 Hold
18
– – ﹤0.01% 1750
2013
Q4 		$0 Hold
18
– – ﹤0.01% 1655
2013
Q3 		$0 Hold
18
– – ﹤0.01% 1641
2013
Q2 		$0 Buy
+18
New +$213 ﹤0.01% 1407

Other funds holding EW

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

New England Securities's EW Position: Q4 2014 in Review

New England Securities increased its Edwards Lifesciences (EW) stake by 384% in Q4 2014, buying an estimated $94K and bringing the position to 5,898 shares worth $125K. The position accounts for 0.04% of the portfolio, ranked #368.

New England Securities first reported a position in EW in Q2 2013 and has held it in 7 quarters since. 556 funds tracked by Wall St. Rank hold EW as of Q4 2014.

  • New England Securities held 5,898 shares of Edwards Lifesciences worth $125K as of Q4 2014.
  • New England Securities bought 4,680 Edwards Lifesciences shares in Q4 2014, an estimated $94K.
  • Edwards Lifesciences made up 0.04% of New England Securities's portfolio in Q4 2014, its #368 holding.
  • New England Securities first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 7 quarters since.
  • 556 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.